, and submicroscopic cases. Overcoming this challenge relies on harnessing the power of molecular
diagnostic tools
as both
diagnostic biomarkers and therapeutic targets for IAs. CircRNAs have demonstrated their influence
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) number of patients and contributing significantly to cancer-related mortality. Conventional
diagnosticSubbotin, Dmitrii,
Ionova, Sofya,
Marakhonov, Andrey,
Saifullina, Elena,
Borovikov, Artem,
Akhmadeeva, Leila,
Chausova, Polina,
Ryzhkova, Oksana,
Zinchenko, Rena,
Kutsev, Sergey,
Murtazina, Aysylu (2024) aids in optimizing
diagnostic processes and reducing the
diagnostic odyssey for patients. Copyright